COM:GENSIGHT-BIOLOGICS
GenSight Biologics S.A.
- Stock
Last Close
0.32
25/11 08:59
Market Cap
31.04M
Beta: -
Volume Today
88.55K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -2.76M - | -6.67M 141.46% | -13.65M 104.67% | -22.08M 61.73% | -24.11M 9.19% | -33.45M 38.74% | -30.71M 8.20% | -34.02M 10.76% | -28.62M 15.87% | -27.63M 3.47% | -26.22M 5.09% | |
depreciation and amortization | 40.31K - | 255.62K 534.12% | 138.65K 45.76% | 202.71K 46.20% | 224K 10.50% | 315K 40.63% | 985K 212.70% | 926K 5.99% | 928K 0.22% | 1.06M 14.33% | 3.03M 185.96% | |
deferred income tax | 29.35K - | 31.50K 7.33% | 27K 14.28% | 27K 0% | 35K 29.63% | 36K 2.86% | 17K 52.78% | -8.89M - | ||||
stock based compensation | 130.95K - | 294.97K 125.26% | 1.53M 419.33% | 4.63M 202.54% | 4.80M 3.57% | 2.42M 49.54% | 1.31M 46.04% | 3.46M 164.35% | 4.83M 39.91% | -3.36M 169.59% | 587K 117.45% | |
change in working capital | 641.51K - | 589.62K 8.09% | -128.88K 121.86% | -2.43M 1,784.52% | 202K 108.32% | 1.90M 838.61% | -145K 107.65% | 5.57M 3,939.31% | 4.84M 13.04% | -3.92M 180.89% | 2.45M 162.67% | |
accounts receivables | -844K - | 791K 193.72% | -698K 188.24% | 756K 208.31% | -1K 100.13% | |||||||
inventory | ||||||||||||
accounts payables | -223K - | 344K 254.26% | 2.40M 597.09% | -2.15M 189.74% | -2.23M 3.81% | |||||||
other working capital | 922K - | 4.43M 380.69% | 3.14M 29.13% | -2.52M 180.23% | 4.69M 286.07% | |||||||
other non cash items | 14.55K - | -11.93K 182.00% | -144 98.79% | 77K 53,572.22% | 410K 432.47% | 416K 1.46% | 8.99M 2,060.34% | 858K 90.45% | 91K 89.39% | -4.89M 5,469.23% | ||
net cash provided by operating activities | -1.95M - | -5.52M 182.88% | -12.09M 119.25% | -19.64M 62.40% | -18.78M 4.38% | -28.38M 51.12% | -28.11M 0.95% | -15.04M 46.49% | -17.14M 13.93% | -33.75M 96.94% | -25.03M 25.84% | |
investments in property plant and equipment | -342.76K - | -189.14K 44.82% | -706.94K 273.76% | -189.22K 73.23% | -236K 24.72% | -791K 235.17% | -76K 90.39% | -6K 92.11% | -32K 433.33% | -252K 687.50% | -10K 96.03% | |
acquisitions net | 7.52K - | |||||||||||
purchases of investments | -31.35K - | -1.40M 4,372.69% | -79.55K 94.33% | -448K - | -26K - | -370K 1,323.08% | ||||||
sales maturities of investments | 1.40M - | 7.77K 99.45% | 16K - | 424K 2,550% | 219K 48.35% | |||||||
other investing activites | -7.52K - | 11K 246.33% | 128K - | 16K - | ||||||||
net cash used for investing activites | -374.11K - | -1.59M 325.36% | 617.45K 138.80% | -170.45K 127.61% | -684K 301.28% | -663K 3.07% | -102K 84.62% | -376K 268.63% | -16K 95.74% | 172K 1,175% | 209K 21.51% | |
debt repayment | -5.67M - | -11.71M 106.47% | -3.07M 73.79% | -7.82M 154.87% | -13.10M 67.49% | |||||||
common stock issued | 19.40M - | 5.80K 99.97% | 30.87M 531,640.62% | 41.58M 34.70% | 21.03M 49.42% | 8K 99.96% | 16.22M 202,675% | 23.57M 45.28% | 28.53M 21.07% | 37K 99.87% | 4.02M 10,756.76% | |
common stock repurchased | -145.23K - | -84K 42.16% | -123K 46.43% | -305K - | -193K 36.72% | -99K 48.70% | ||||||
dividends paid | -1.42M - | -193K 86.40% | ||||||||||
other financing activites | 678K - | 2.30M - | -1K 100.04% | 10.70M - | 22.00M 105.73% | -1K 100.00% | 8.27M 826,700% | |||||
net cash used provided by financing activities | 19.40M - | 683.80K 96.48% | 30.87M 4,414.09% | 43.73M 41.68% | 20.95M 52.11% | -115K 100.55% | 21.25M 18,573.91% | 33.86M 59.37% | 23.74M 29.89% | 95K 99.60% | 16.23M 16,981.05% | |
effect of forex changes on cash | 1 - | -1 - | -14K 1,399,900% | -47K 235.71% | -22K 53.19% | 254K 1,254.55% | -238K 193.70% | -193K 18.91% | 119K 161.66% | |||
net change in cash | 17.07M - | -6.42M 137.62% | 19.39M 401.85% | 23.92M 23.37% | 1.47M 93.87% | -29.21M 2,092.29% | -6.99M 76.06% | 18.69M 367.39% | 6.34M 66.06% | -33.68M 630.80% | -8.48M 74.83% | |
cash at beginning of period | 18.85K - | 17.09M 90,600.36% | 10.67M 37.58% | 30.06M 181.74% | 53.98M 79.58% | 55.45M 2.72% | 26.24M 52.67% | 19.25M 26.64% | 37.94M 97.11% | 44.29M 16.72% | 10.61M 76.04% | |
cash at end of period | 17.09M - | 10.67M 37.58% | 30.06M 181.74% | 53.98M 79.58% | 55.45M 2.72% | 26.24M 52.67% | 19.25M 26.64% | 37.94M 97.11% | 44.29M 16.72% | 10.61M 76.05% | 2.13M 79.89% | |
operating cash flow | -1.95M - | -5.52M 182.88% | -12.09M 119.25% | -19.64M 62.40% | -18.78M 4.38% | -28.38M 51.12% | -28.11M 0.95% | -15.04M 46.49% | -17.14M 13.93% | -33.75M 96.94% | -25.03M 25.84% | |
capital expenditure | -342.76K - | -189.14K 44.82% | -706.94K 273.76% | -189.22K 73.23% | -236K 24.72% | -791K 235.17% | -76K 90.39% | -6K 92.11% | -32K 433.33% | -252K 687.50% | -10K 96.03% | |
free cash flow | -2.29M - | -5.71M 148.84% | -12.80M 124.37% | -19.83M 54.91% | -19.02M 4.10% | -29.17M 53.40% | -28.19M 3.38% | -15.05M 46.61% | -17.17M 14.09% | -34.01M 98.04% | -25.04M 26.36% |
All numbers in EUR (except ratios and percentages)